These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30230387)

  • 1. Synthesis and structure-activity relationships of 2- and/or 4-halogenated 13β- and 13α-estrone derivatives as enzyme inhibitors of estrogen biosynthesis.
    Bacsa I; Herman BE; Jójárt R; Herman KS; Wölfling J; Schneider G; Varga M; Tömböly C; Rižner TL; Szécsi M; Mernyák E
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1271-1282. PubMed ID: 30230387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of A-ring halogenated 13α-estrone derivatives as potential 17β-HSD1 inhibitors.
    Bacsa I; Jójárt R; Schneider G; Wölfling J; Maróti P; Herman BE; Szécsi M; Mernyák E
    Steroids; 2015 Dec; 104():230-6. PubMed ID: 26476182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative investigation of the in vitro inhibitory potencies of 13-epimeric estrones and D-secoestrones towards 17β-hydroxysteroid dehydrogenase type 1.
    Herman BE; Szabó J; Bacsa I; Wölfling J; Schneider G; Bálint M; Hetényi C; Mernyák E; Szécsi M
    J Enzyme Inhib Med Chem; 2016; 31(sup3):61-69. PubMed ID: 27424610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and in vitro pharmacological evaluation of N-[(1-benzyl-1,2,3-triazol-4-yl)methyl]-carboxamides on d-secoestrone scaffolds.
    Szabó J; Bacsa I; Wölfling J; Schneider G; Zupkó I; Varga M; Herman BE; Kalmár L; Szécsi M; Mernyák E
    J Enzyme Inhib Med Chem; 2016 Aug; 31(4):574-9. PubMed ID: 26360618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of substituted 15β-alkoxy estrone derivatives and their cofactor-dependent inhibitory effect on 17β-HSD1.
    Herman BE; Kiss A; Wölfling J; Mernyák E; Szécsi M; Schneider G
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1271-1286. PubMed ID: 31307240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of analogues of estrone-3-O-sulfamate as potent steroid sulfatase inhibitors.
    Lawrence Woo LW; Leblond B; Purohit A; Potter BV
    Bioorg Med Chem; 2012 Apr; 20(8):2506-19. PubMed ID: 22455789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrone C15 derivatives--a new class of 17beta-hydroxysteroid dehydrogenase type 1 inhibitors.
    Messinger J; Husen B; Koskimies P; Hirvelä L; Kallio L; Saarenketo P; Thole H
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):216-24. PubMed ID: 19014997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
    Smuc T; Rizner TL
    Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroidal ferrocenes as potential enzyme inhibitors of the estrogen biosynthesis.
    Herman BE; Gardi J; Julesz J; Tömböly C; Szánti-Pintér E; Fehér K; Skoda-Földes R; Szécsi M
    Biol Futur; 2020 Sep; 71(3):249-264. PubMed ID: 34554507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen formation in endometrial and cervix cancer cell lines: involvement of aromatase, steroid sulfatase and 17beta-hydroxysteroid dehydrogenases (types 1, 5, 7 and 12).
    Fournier MA; Poirier D
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):142-5. PubMed ID: 18817841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pd-Catalyzed microwave-assisted synthesis of phosphonated 13α-estrones as potential OATP2B1, 17β-HSD1 and/or STS inhibitors.
    Jójárt R; Pécsy S; Keglevich G; Szécsi M; Rigó R; Özvegy-Laczka C; Kecskeméti G; Mernyák E
    Beilstein J Org Chem; 2018; 14():2838-2845. PubMed ID: 30498534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, Biological Evaluation and Docking Studies of 13-Epimeric 10-fluoro- and 10-Chloroestra-1,4-dien-3-ones as Potential Aromatase Inhibitors.
    Jójárt R; Traj P; Kovács É; Horváth Á; Schneider G; Szécsi M; Pál A; Paragi G; Mernyák E
    Molecules; 2019 May; 24(9):. PubMed ID: 31072017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel, potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.
    Allan GM; Bubert C; Vicker N; Smith A; Tutill HJ; Purohit A; Reed MJ; Potter BV
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):204-7. PubMed ID: 16337736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen O-sulfamates and their analogues: Clinical steroid sulfatase inhibitors with broad potential.
    Thomas MP; Potter BV
    J Steroid Biochem Mol Biol; 2015 Sep; 153():160-9. PubMed ID: 25843211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based design, synthesis and in vitro characterization of potent 17beta-hydroxysteroid dehydrogenase type 1 inhibitors based on 2-substitutions of estrone and D-homo-estrone.
    Möller G; Deluca D; Gege C; Rosinus A; Kowalik D; Peters O; Droescher P; Elger W; Adamski J; Hillisch A
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6740-4. PubMed ID: 19836949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of AKR1C inhibitory properties of A-ring halogenated oestrone derivatives.
    Sinreih M; Jójárt R; Kele Z; Büdefeld T; Paragi G; Mernyák E; Rižner TL
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1500-1508. PubMed ID: 34227437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of 16β-derivatives of 3-(2-bromoethyl)-estra-1,3,5(10)-trien-17β-ol as inhibitors of 17β-HSD1 and/or steroid sulfatase for the treatment of estrogen-dependent diseases.
    Lespérance M; Roy J; Djiemeny Ngueta A; Maltais R; Poirier D
    Steroids; 2021 Aug; 172():108856. PubMed ID: 33945801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The difluoromethylene group as a replacement for the labile oxygen in steroid sulfates: a new approach to steroid sulfatase inhibitors.
    Lapierre J; Ahmed V; Chen MJ; Ispahany M; Guillemette JG; Taylor SD
    Bioorg Med Chem Lett; 2004 Jan; 14(1):151-5. PubMed ID: 14684318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical synthesis, characterisation and biological evaluation of furanic-estradiol derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 1.
    Farhane S; Laplante Y; Poirier D
    Med Chem; 2011 Mar; 7(2):80-91. PubMed ID: 21222612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of steroid sulphatase and oestradiol 17 beta-hydroxysteroid dehydrogenase in breast cancer.
    Purohit A; Singh A; Reed MJ
    Biochem Soc Trans; 1999 Feb; 27(2):323-7. PubMed ID: 10093756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.